A B2B guide to veterinary patient warming. Evaluate forced-air vs conductive systems, ACVAA 2025 guidelines, FDA regulations, MAUDE burn statistics, and disposable vs reusable ROI.

In small-animal veterinary medicine, perioperative hypothermia is the most common complication of general anesthesia, affecting the vast majority of feline and canine surgical patients. Anesthetic drugs depress the hypothalamus, impairing thermoregulation, while vasodilation accelerates heat loss to the cold operating room environment. When a patient's core body temperature drops, the clinical consequences are immediate and far-reaching: impaired drug metabolism, prolonged recovery times, cardiac arrhythmias, altered coagulation, and delayed wound healing.

Despite these clear clinical risks, the selection, safety monitoring, and operational integration of patient-warming equipment are frequently underestimated in general practice (GP) clinics. To help practice owners, medical directors, and anesthesia leads make evidence-based purchasing decisions, this guide compares the efficacy of forced-air, conductive, and fluid-warming systems, analyzes device-safety records using FDA MAUDE data, and evaluates the capital-versus-consumable return on investment (ROI) for veterinary practices. (For the broader anesthesia-equipment purchase, see our anesthesia machine buyer guide and clinic equipment budget checklist.)

Fast answer: What is the warming device landscape?

Active patient warming is no longer optional; it is an established consensus standard endorsed by the American Animal Hospital Association (AAHA) and the American College of Veterinary Anesthesia and Analgesia (ACVAA). The ACVAA 2025 guidelines mandate monitoring temperature at least every 30 minutes during anesthesia and recovery, and starting active warming if the temperature drops below 37.8°C (100°F).

The major equipment categories include:

Forced-Air Warmers (Bair Hugger, Darvall Cocoon, HoverHeat): These blow heated air through specialized blankets, providing the fastest and most consistent core temperature control in head-to-head veterinary clinical studies.
Conductive/Resistive Warming (HotDog): These utilize carbon-conductive underbody blankets to transfer heat directly through contact, eliminating convective airflow in the surgical suite.
Circulating-Water Blankets (Gaymar/Stryker): An older technology that transfers heat via warmed water circulating through vinyl pads; they have lower thermal transfer rates and carry a high risk of leaking and contamination.
IV Fluid Warmers (Level 1 Hotline, Belmont): Essential adjuncts that warm intravenous fluids before infusion to prevent the cooling of the core by room-temperature crystalloids.

FDA MAUDE pharmacovigilance data reveals that while patient warmers are generally safe, burns and mechanical failures are documented risks, with 314 burn reports across 35,492 adverse events. Recent safety alerts, including the January 2025 FDA Dear Veterinarian letter regarding Megadyne human grounding-pad burns and 2024-2025 HotDog veterinary controller recalls, underscore the need for strict compliance with manufacturer operating protocols. For a GP clinic, the choice between forced-air and conductive systems often hinges on the ROI of disposable consumables ($13 to $20 per single-use blanket) versus the higher upfront cost of reusable, wash-tolerant heating pads.

Why is perioperative hypothermia the anesthesia complication clinics underestimate?

General anesthesia shuts down a patient's primary defense against cold: behavioral avoidance, shivering, and vasoconstriction. Once anesthetized, heat loss occurs through four pathways:

Radiation: Loss of heat to the cooler surrounding air and walls (accounts for the largest share of loss).
Convection: Air currents moving across the patient's exposed skin and fur.
Conduction: Transfer of heat from the patient's body to the cold metal surgical table.
Evaporation: Evaporative cooling from surgical prep solutions (alcohol, scrub) and moisture loss from the respiratory tract due to dry anesthetic gases.

Prevalence and the Redondo Landmark Study

The scale of this issue was quantified in landmark clinical studies by Redondo et al. (2012), which remain the strongest veterinary-specific prevalence data available. The researchers evaluated 1,525 anesthetized dogs and found that 83.6% of dogs suffered from perioperative hypothermia. In cats, the prevalence was even higher, reaching 96.7% of all anesthetized feline patients.

Despite this high occurrence, many veterinary teams treat mild-to-moderate hypothermia as an inevitable, benign part of the recovery process. However, veterinary clinical trials indicate that even mild hypothermia prolongs recovery times, depresses immune function, and compromises patient safety.

The Human-vs-Veterinary SSI Risk Discrepancy

In human medicine, maintaining normothermia is heavily prioritized because clinical data shows that hypothermia increases the rate of surgical site infections (SSIs). One systematic review of human perioperative warming found SSI risk rose roughly 221% for every degree Celsius a patient's core temperature fell below 35°C.

However, general practice veterinarians must note a key difference in the veterinary literature. A retrospective study of 777 dogs and cats by Beal et al. (2000) evaluated risk factors for surgical site infections in veterinary patients. Interestingly, they found that mild-to-moderate hypothermia was not an independent risk factor for SSI, unlike in human patients. This does not mean hypothermia is safe; it simply means the primary complications in companion animals are hematologic, cardiovascular, and metabolic, rather than infectious. Clinicians should not use the human 221% SSI figure to scare veterinary teams; instead, they should focus on the validated animal complications: prolonged drug clearance, hypotension, and poor anesthetic recovery quality.

What are the warming-device families, and which brands sit in each?

Veterinary clinics typically choose between four active warming categories:

1. Forced-Air Warming (FAW)

Forced-air warmers consist of a blower unit that heats ambient air, filters it, and pushes it through a flexible hose into a perforated blanket draped over or placed under the patient.

Key Brands: Bair Hugger (manufactured by Solventum, formerly 3M), Darvall Cocoon, and HoverHeat (distributed by ZZ Medical).
Clinical Efficacy: Excellent. The constant movement of warm air creates a microclimate around the patient, effectively blocking convective heat loss and maximizing thermal transfer.
Operational Aspect: Standard blankets are single-use disposable items, creating an ongoing operational expense.

2. Conductive/Resistive Warming

Resistive warming systems utilize flexible fabric pads containing carbon-conductive polymers that heat up when an electrical current is applied.

Key Brands: HotDog Patient Warming (manufactured by Augustine Temperature Management).
Clinical Efficacy: High. They transfer heat via direct conduction. Because they do not blow air, they eliminate any potential for convective currents to disturb the sterile field.
Operational Aspect: The pads are reusable, water-resistant, and can be wiped down with standard disinfectants between patients.

3. Circulating-Water Blankets

These systems consist of a water reservoir heater and pump that circulates warmed water through a network of tubes embedded in a flexible vinyl pad.

Key Brands: Gaymar (Stryker), Cincinnati Sub-Zero (CSZ/Stryker).
Clinical Efficacy: Moderate-to-poor. Water has a high specific heat capacity, but vinyl is a poor thermal conductor. Heat transfer is slow, and the pads lose temperature rapidly if the flow is restricted.
Operational Aspect: Vinyl pads are prone to punctures from animal claws or surgical instruments, leading to water leaks. Damp surfaces accelerate heat loss, turning the warmer into a cooling pad. They are also difficult to disinfect, presenting a risk of bacterial contamination.

4. Intravenous (IV) Fluid Warmers

Fluid warmers heat intravenous fluids or blood products as they flow through a disposable cassette or tube inserted into a heating block or bath.

Key Brands: Level 1 Hotline (Smiths Medical/ICU Medical) and Belmont Rapid Infuser.
Clinical Efficacy: Highly specific. Warmed fluids do not actively warm the patient's core, but they prevent the significant cooling effect that occurs when room-temperature (or refrigerated) crystalloids from your infusion or syringe pump are administered to small patients during long procedures.

Forced-Air vs Conductive vs Circulating-Water: Efficacy in Animal Data

When choosing equipment, practice managers must evaluate head-to-head efficacy data. Several peer-reviewed studies have compared these technologies in animal models:

The Porcine Model Study (Dent, Stevens, and Clymer 2016): Published in Veterinary Sciences, this study compared forced-air warming, resistive polymer (conductive) warming, and circulating-water blankets in a porcine surgical model. The researchers found that forced-air warming provided the most consistent core temperature control and resulted in the fewest out-of-specification hypothermic episodes. Conductive polymer warming performed well but required larger surface contact areas to match forced-air's thermal transfer rate. Circulating-water pads performed the poorest, with core temperatures dropping significantly during the first hour of anesthesia.
The Foundational Veterinary RCT (Machon, Raffe, and Robinson 1999): In a randomized clinical trial published in Veterinary Surgery, the authors evaluated forced-air warming in dogs undergoing orthopedic or soft-tissue surgery. Dogs actively warmed with forced-air maintained a median core temperature 0.9°C higher than control dogs at the end of surgery. The study also validated that rectal temperature measurements closely correlated with esophageal probe measurements when using forced-air blankets, providing clinics with a practical, non-invasive monitoring route.

What does the MAUDE database actually show about warmer burns and failures?

Because veterinary clinics routinely purchase refurbished human-hospital medical equipment to save money, they inherit the safety records of the human device market. To evaluate the real-world failure modes of these warming systems, we conducted a target audit of the FDA's Manufacturer and User Facility Device Experience (MAUDE) database, recomputed on July 8, 2026.

Product Classification and Dataset Scope

The FDA regulates human patient-warming devices under specific product codes:

DWJ: System, Thermal, Regulating (Class II, 21 CFR 870.5900)
LGZ: Infusion Fluid Warmer (Class II, 21 CFR 880.5725)
FOH: Water Mattress, Temperature Regulated (Class I, 21 CFR 880.5560)
BSB: System, Hypothermia/Hyperthermia, Clinical (Class II)

Our analysis of the FDA MAUDE database identified 35,492 unique adverse-event reports (deduplicated by report number) across these product codes.

Burn-Keyword Analysis

To isolate actual patient safety events, we filtered the database for reports containing the term "burn" in the patient problem descriptions. This identified 314 unique burn reports out of the 35,492 total. Burns cluster in fluid-warming systems and targeted-temperature-management (TTM) contact pads; forced-air warmers account for a small minority:

Device Family	Approx. Burn Reports	Typical Failure Mode
Level 1 (Smiths/ICU) fluid-warming systems	~97	Cassette leakage, sensor malfunction, or overheating
Arctic Sun and other TTM contact-pad systems	~45–50	Adhesive/pad contact irritation or prolonged-contact burns
Bair Hugger and other forced-air warmers	~23	"Hosing" — the bare hose placed directly against the skin
Other / unknown / circulating-water	~115–150	Vinyl mattress ruptures, control-board failure, or improper use

Brand attribution is approximate because MAUDE's brand_name is a free-text field and some entries are generic or null; the report total (314) and the forced-air count (~23) are stable, but the intermediate buckets shift with how multi-brand and unbranded reports are grouped. The clinical takeaway does not change: burns are concentrated in fluid warmers and conductive contact pads, not in forced-air airflow.

Safety Analysis: Forced-air blowers (like the Bair Hugger) are highly resistant to causing burns when operated correctly. Almost all ~23 reported Bair Hugger burns involved "hosing" — a prohibited practice where the operator places the bare hose directly under or against the patient's skin without attaching it to a perforated blanket. This concentrates high-temperature air in a single spot, causing rapid thermal injury.

What do the 2024-2025 Megadyne and HotDog recalls mean for a buyer today?

Practice managers must look beyond historical statistics to the most recent safety signals on record. Between late 2024 and early 2025, two major product safety recalls occurred that directly impact veterinary procurement:

1. The Megadyne Grounding-Pad Burns (January 2025)

On January 14, 2025, the FDA Center for Veterinary Medicine (CVM) issued an urgent Dear Veterinarian letter warning the veterinary community about the risk of severe animal burns associated with human electrosurgical grounding pads.

The Device: Megadyne Mega Soft and Mega 2000 patient return electrodes (manufactured by Megadyne Medical Products, a Johnson & Johnson company). These are large, reusable silicone mats placed under the patient during surgery that act as both a grounding pad for monopolar electrosurgery and a passive insulator.
The Failure: The FDA received multiple reports of animals suffering severe, deep-tissue burns at the contact points. Because these human-cleared devices were designed for human anatomy and weight distribution, they did not function safely under the concentrated pressure points of small, bony veterinary patients (particularly small dogs and cats). The FDA CVM mandated updated veterinary-specific labeling and warned clinics to stop using them without protective barriers.

2. The HotDog Controller and Mattress Recalls (Dec 2024 - Feb 2025)

During the same period, the FDA posted a series of Augustine Temperature Management recalls affecting the HotDog Patient Warming line. These were two distinct problems, and buyers should understand the difference:

Controller self-test failures (posted Dec 2024 - Jan 2025): Multiple controller models — including the veterinary-specific WC77V plus the WC71, WC77, and MP (Hillrom Model 2083516) units — were recalled (e.g., FDA recalls Z-0700-2025, Z-0702-2025, Z-0839-2025, Z-0843-2025) because they could throw a power-on self-test error or require updated use instructions that, if missed, could allow inaccurate temperature control or display readings.
Underbody mattress over-molding (posted Feb 2025): Separately, the HotDog underbody warming mattress (REF US530) was recalled (Z-1199-2025) because the over-molding that stabilizes the cable-to-mattress connection degrades after roughly a year of use, causing intermittent connection failures.
The Buyer Action: Any clinic purchasing a used or refurbished HotDog system today must confirm that both the controller and the mattress are cleared of these 2024-2025 recalls, or that the units have been factory-serviced and the firmware/instructions updated.

Disposable vs Reusable: The Real Cost and Waste Trade-off

For a general practice clinic performing 150 surgeries per month, the choice between forced-air and conductive warming is frequently an economic decision based on consumable costs.

Forced-Air (Bair Hugger-Class) ROI Model

Forced-air blowers are cheap to acquire (a refurbished Model 775 blower is readily available for $1,000 to $1,500), but they require single-use disposable blankets.

Consumable Cost: $13.00 to $20.00 per blanket.
Monthly Consumable Cost (150 surgeries): 150 x $15.00 = $2,250.00.
Annual Consumable Cost: $27,000.00.
Waste Footprint: 1,800 non-biodegradable polyester/paper blankets sent to the landfill annually.

Reusable Warming (HoverHeat Forced-Air or HotDog Conductive) ROI Model

Reusable systems — either reusable forced-air blankets (like HoverHeat's wash-tolerant set) or conductive underbody pads (like HotDog) — require a higher initial capital outlay but have near-zero ongoing consumable costs.

Initial Capital Cost: A complete reusable underbody system (controller + medium and large wash-tolerant pads) costs approximately $1,295 to $2,500 upfront.
Consumable Cost: $0.00.
Maintenance Cost: $0.00 (wiped down with standard clinic disinfectant).

The Break-Even Analysis

If a clinic purchases a $2,000 reusable system instead of a $1,000 forced-air blower that requires $15.00 disposable blankets, the math is straightforward:

Extra capital spent up front: $1,000
Consumable saved per procedure: $15.00
Break-even point: $1,000 ÷ $15.00 ≈ 67 procedures

In a GP clinic performing 150 surgeries per month, the reusable system pays for itself in less than 15 days of clinical operation. For high-volume spay/neuter clinics or general practices, the financial and environmental benefits of reusable warming pads are clear.

How should warming fit into the anesthesia and recovery SOP?

Active patient warming is not just about turning on a machine during surgery; it must be integrated into the clinic's standard operating procedures (SOP) — alongside machine leak-checks and scavenging — across three phases:

1. Pre-Warming (The Pre-op Phase)

Heat loss is fastest during the first 20 minutes of anesthesia, driven by the rapid vasodilation caused by induction agents (propofol, alfaxalone). Pre-warming the patient with active forced-air for 15 to 20 minutes prior to induction maintains peripheral vasoconstriction, significantly reducing the initial core-to-peripheral heat redistribution.

2. Intraoperative Phase (The OR Phase)

Continuous Monitoring: A dedicated temperature probe (esophageal or rectal) — a core function of any anesthesia monitor — should be placed immediately after intubation. Temperature must be recorded on the anesthesia sheet every 15 minutes.
Warming Threshold: Turn on the active warmer immediately. Do not wait for the patient's temperature to drop. If the core temperature rises above 39.2°C (102.5°F), turn off the warmer to prevent hyperthermia.
Barrier Rule: Always place a clean, thin towel or disposable drape between a conductive heating pad and the patient's skin. Never place a prep-dampened animal directly on a heating element.

3. Post-operative Phase (The Recovery Phase)

Many clinics turn off warming as soon as the vaporizer is shut off. However, patients continue to lose heat in the recovery cage.

The ACVAA 2025 Recovery Rule: Continue temperature monitoring every 30 minutes in recovery. Keep active warming in place until the patient's core temperature reaches 37.8°C (100°F) and the patient is sternal and extubated.

A Clinical SOP Check: Implementing active warming in your practice

To ensure patient safety and compliance with the ACVAA 2025 guidelines, clinics should adopt the following checklist for every surgical procedure:

Pre-op Triage: Assess the patient's body condition score (BCS). Cachexic, pediatric, and geriatric patients have minimal subcutaneous fat and lose heat at an accelerated rate. Pre-warm these patients for 20 minutes prior to induction.
Visual Inspection: Before placing any patient on a warming device, visually inspect the pad or blanket. Check for punctures in vinyl water blankets, tears in conductive fabric, or blockages in forced-air hoses.
Sensor Placement: Ensure the temperature probe (rectal or esophageal) is inserted and secured. Esophageal probes must be positioned in the distal third of the esophagus (near the heart) for accurate core readings; placing them too shallow yields room-air-contaminated values.
Hourly Audits: During recovery, do not rely on a single visual check. Perform a physical touch check of the patient's extremities (paws, ears) and record core body temperature every 30 minutes until the target of 37.8°C (100°F) is reached.

Frequently Asked Questions

Are warming devices FDA-approved for animals, or are clinics using human devices?

The FDA Center for Veterinary Medicine (CVM) does not require premarket approval, 510(k) clearance, or PMA filing for devices intended solely for animal use. Therefore, there is no such thing as an "FDA-approved veterinary warmer." Manufacturers of veterinary-only devices (such as Darvall or specific veterinary HotDog models) can legally sell their equipment without filing data with the FDA. Consequently, many veterinary clinics purchase cleared human-hospital devices (like the Bair Hugger Model 775) and use them off-label under veterinary discretion.

Is the Bair Hugger airflow / surgical-site-infection lawsuit relevant to veterinary surgery?

In human orthopedics, a massive product liability lawsuit argued that the hot air rising from under-body Bair Hugger blankets created waste-heat convective currents that carried floor bacteria upward into the sterile surgical field, increasing surgical site infections (SSIs) in joint replacement surgeries.

The FDA Stance: After an exhaustive review, the FDA issued a safety communication stating that it found no consistent association between forced-air warming and surgical site infections, recommending that healthcare providers continue using them to prevent hypothermia.
The Veterinary Stance: In veterinary medicine, the risk is considered negligible due to different draping styles, smaller patient sizes, and the lack of clinical evidence linking forced-air to SSIs in animals. The established risk of hypothermia far outweighs the unproven risk of airflow-related infection.

What is the cheapest safe way to start active warming in a small GP clinic?

For a start-up or low-budget GP clinic, the cheapest entry point is a refurbished human forced-air blower (such as a Bair Hugger 750 or 775 unit) purchased from a reputable medical reseller for about $800 to $1,000, combined with reusable, wash-tolerant veterinary forced-air blankets (like the Darvall reusable blankets) to eliminate the high cost of disposable single-use items. Never use unmonitored human heating pads, seed bags, or hot-water bottles, as they lack safety thermostats and frequently cause severe contact burns.

Sources

U.S. Food and Drug Administration. (2024). How FDA Regulates Animal Devices. FDA Center for Veterinary Medicine. https://www.fda.gov/animal-veterinary/animal-health-literacy/how-fda-regulates-animal-devices
American Animal Hospital Association. (2020). 2020 AAHA Anesthesia and Monitoring Guidelines for Dogs and Cats. AAHA. https://www.aaha.org/wp-content/uploads/globalassets/02-guidelines/2020-anesthesia/anesthesia_and_monitoring_guidelines_final.pdf
American College of Veterinary Anesthesia and Analgesia. (2025). ACVAA 2025 Small Animal Anesthesia Monitoring Recommendations. Veterinary Anaesthesia and Analgesia, 52(3), 377-385. https://acvaa.org/wp-content/uploads/2025/08/PIIS1467298725000716-2.pdf
Dent, A., Stevens, M., & Clymer, J. (2016). Forced-Air Warming in Porcine Surgical Patients. Veterinary Sciences, 3(3), 22. https://www.mdpi.com/2306-7381/3/3/22
Machon, R. G., Raffe, M. R., & Robinson, E. P. (1999). Comparison of a forced warm-air system and a circulating water blanket for prevention of hypothermia in anesthetized dogs. Veterinary Surgery, 28(4), 301-310. https://pubmed.ncbi.nlm.nih.gov/10424713/
FDA CVM. (2025). Dear Veterinarian: Animal Burn Risk Linked to Human electrosurgical grounding pads. U.S. Food and Drug Administration / dvm360. https://www.dvm360.com/view/fda-notifies-veterinarians-of-animal-burn-risk-linked-to-human-medical-devices
U.S. Food and Drug Administration. (2025). HotDog Patient Warming recalls: controllers WC71/WC77/WC77V/MP (Z-0700-2025, Z-0702-2025, Z-0839-2025, Z-0843-2025) and underbody mattress REF US530 (Z-1199-2025). FDA Medical Device Recalls database. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm

Vet Med Guide

Veterinary Patient Warming Devices: Hypothermia, Forced-Air Burns, and the MAUDE Data